{"id":"W2922206684","doi":"10.1093/eurheartj/ehz119","title":"Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sanofi K.K.; Pfizer Japan; Boehringer Ingelheim Japan; Astellas Foundation for Research on Metabolic Disorders; Kyowa Hakko Kirin; Teijin Pharma; Daiichi-Sankyo; Ministry of Education, Culture, Sports, Science and Technology; MSD K.K.; Asahi Kasei Pharma Corporation; Astellas Pharma US; Kowa Company; Chugai Pharmaceutical; Eisai Canada; Mitsubishi Tanabe Pharma Corporation; Nihon Medi-Physics; Takeda Pharmaceutical Company; Daiichi Sankyo Europe; Kowa Pharmaceutical Europe; Medtronic; Dainippon Sumitomo Pharma; Pfizer; Novartis Pharma; Otsuka Pharmaceutical; Japan Agency for Medical Research and Development; Boston Scientific Japan","keywords":"Medicine; Febuxostat; Internal medicine; Hyperuricemia; Uric acid","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001017078,0.0005030668,0.001237146,0.0001832958,0.0002305105,0.0004020619,0.0002964298,0.0003679979,0.001186303],"category_scores_gemma":[0.0007539029,0.0002425365,0.0007513376,0.0002291564,0.0001654654,0.000147892,0.0002227865,0.0005774119,0.0001636587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002167758,"about_ca_system_score_gemma":0.0004898377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004804827,"about_ca_topic_score_gemma":0.0009681872,"domain_scores_codex":[0.9996815,0.0001782937,0.000024984,0.00004064464,0.00003880736,0.00003573875],"domain_scores_gemma":[0.9994569,0.00009459265,0.0001956862,0.00003471639,0.0000350931,0.0001830239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6439152,0.00736146,0.2788725,0.001625338,0.004439031,0.0006187928,0.00008698033,0.0006343769,0.008343183,0.0002248988,0.002356531,0.0515217],"study_design_scores_gemma":[0.2587771,0.05187261,0.6741294,0.0001897796,0.005912424,0.0009357061,0.00007026937,0.001484238,0.002519943,0.0001910941,0.00388017,0.0000372884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907923,0.005810286,0.0003235236,0.0002109318,0.00009838489,0.0005993872,0.0007646554,0.00002027885,0.001380348],"genre_scores_gemma":[0.9934242,0.002362765,0.001053145,0.0003360053,0.000211962,0.0006816864,0.001111135,0.000003691581,0.0008154801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001237146,"threshold_uncertainty_score":0.005378902,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03688836735067023,"score_gpt":0.3152020890768249,"score_spread":0.2783137217261547,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}